RxDoctor Payments Data

Philip Boucher

Pediatrics · Omaha, NENPI 1962796839

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $10,290 of the $10,306 with a category attached, or 99.8%. AstraZeneca accounts for 99.8% of it on its own, with 1 other manufacturer making up the rest. Among pediatrics clinicians in NE with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$10,306in general payments, 2019–2025

Across 2 payments — averaging $5153.13 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$10K
  • Sanofi$16
$939,623in research payments, 2019–2025

Across 126 payments — averaging $7457.33 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • GSK$557K
  • Novavax Inc$181K
  • Modernatx, Inc.$143K
  • Sanofi Pasteur Inc.$59K

What the payments were for

  • Consulting fees$10,290100%
  • Food & beverage$160%

General payments by program year

24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AstraZeneca1$10,290
Sanofi1$16

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$10,306 in reported general payments places this provider in the 95th percentile of 308 pediatrics providers in Nebraska.

See all pediatrics providers in Nebraska →

Other pediatrics in Omaha

See the full list for Nebraska →

Where these figures come from

Is this you, or does something look wrong? →